Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

NCT00491855 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Cancer

Interventions

DRUG: Bevacizumab
DRUG: Oxaliplatin
DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center